Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-30, Stock:JNJ, The news for the past five days is as follows:
2021-11-22: NEWS1: Kevin O'Leary says the 'real opportunity' for Bitcoin will come from this overlooked group of investors — but he's still a big fan of blue chip dividend stocks.NEWS2: One dose of the J&J COVID-19 vaccine is ‘certainly not enough’: Doctor.NEWS3: J&J’s Push for Settlement Talks Rebuffed by Talc Cancer Victims.NEWS4: REFILE-U.S. administers 452.6 mln doses of COVID-19 vaccines - CDC.NEWS5: Cramer's Mad Money Recap 11/22: Morgan Stanley, Centene, J&J.NEWS6: How Scale Went Out of Fashion in Corporate America.NEWS7: Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots.NEWS8: COVID-19 cases and hospitalizations on the rise ahead of holiday gatherings.NEWS9: FDA Authorizes PFE & MRNA's COVID-19 Boosters for All Adults.NEWS10: Implied Volatility Surging for Johnson & Johnson (JNJ) Stock Options.NEWS11: UPDATE 1-EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'.NEWS12: EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'.NEWS13: 7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation.NEWS14: First COVID vaccine doses donated by EU begin arriving in Africa- GAVI.NEWS15: Vaccine-Makers Edge Higher as Regulators OK Boosters for All Adults.
2021-11-23: NEWS1: COVID-19 vaccines have ‘proved their merit at this point’: Doctor.NEWS2: Top Analyst Reports for Johnson & Johnson, Netflix & Oracle.NEWS3: Countries pushing vaccine IP waivers ‘want to take advantage of the technology’: Fmr. U.S. Commerce Secretary.NEWS4: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS5: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS6: Will Investors Benefit From Johnson & Johnson's Breakup?.NEWS7: 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout.
2021-11-24: NEWS1: COVID-19: ‘Vaccines absolutely decrease the risk of transmission’, doctor says.NEWS2: Mario Gabelli says more companies will catch the 'contagion' to split up — watch for these 4 potentially lucrative breakups.NEWS3: 10 Blue Chip Dividend Stocks with Over 8% Yield.NEWS4: The Key Issues in Picking an Active or Passive Fund.NEWS5: Germany mulls a lockdown as COVID cases rise in Europe.NEWS6: U.S. has already seen more COVID deaths in 2021 than 2020 before vaccines were available, as experts again warn pandemic is not over.NEWS7: Canada clears import of J&J COVID-19 vaccine doses made at Emergent plant.NEWS8: UPDATE 2-Canada clears import of J&J COVID-19 vaccine doses made at Emergent plant.NEWS9: Johnson & Johnson COVID vaccine wins full approval in Canada in first major regulatory nod.NEWS10: UPDATE 2-Canada gives full approval to J&J's single-shot COVID-19 vaccine.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Netflix, Oracle, PepsiCo and Verizon Communications.NEWS12: CVS, Walmart Fall as Ohio Jury Rules Them Guilty in Opioid Crisis.
2021-11-26: NEWS1: What the newly discovered COVID-19 variants means for investors: Stifel chief equity strategist.NEWS2: Vaccines 'still the backbone of everything we do' amid any variants, doctor explains.NEWS3: Market selloff: COVID-19 news 'caught people by surprise' on shortened day, strategist explains.NEWS4: Stocks fall, Merck drops on COVID-19 pill effectiveness, air travel hits pandemic high, more PPP fraud.NEWS5: Airlines and cruises take a hit, Zoom and vaccine stocks up.NEWS6: Hospital capacity is key for COVID-19 containment going forward: Oppenheimer analyst.NEWS7: 'Travel bans don't work,' doctor explains amid reports of newly discovered variant.NEWS8: Market strategist details 'the critical issue' to understand about risk from new COVID-19 variant.NEWS9: Better Buy: Johnson & Johnson or All 30 Dow Jones Stocks?.NEWS10: Stocks down after discovery of new COVID-19 variant.NEWS11: Pfizer/BioNTech's COVID Jab Gets CHMP Nod for Kids Aged 5-11.NEWS12: Pharma Stock Roundup: FDA Nod to COVID Jab for All Adults, CHMP Nod to Shot for Kids.NEWS13: Here's Why We Think Johnson & Johnson (NYSE:JNJ) Is Well Worth Watching.
2021-11-29: NEWS1: Doctor explains Omicron and the possibility of more COVID-19 variants.NEWS2: US STOCKS-Wall Street rebounds after virus-related sell-off.NEWS3: UPDATE 4-U.S. CDC says all adults should get COVID-19 booster shots.NEWS4: Key takeaways from President Biden's comments on new COVID-19 variant.NEWS5: Omicron: What we know so far about the new COVID-19 variant.NEWS6: Omicron variant may mean stock market rally is on hold: Goldman Sachs.NEWS7: Omicron Variant Has Covid-19 Vaccine Makers Preparing for Worst Case.NEWS8: Omicron variant: ‘There probably are cases’ in the U.S. but not yet in large numbers, professor says.NEWS9: UPDATE 4-Biden warns against Omicron panic, pledges no new lockdowns.NEWS10: Rep. Perlmutter (D-CO) talks COVID, Build Back Better bill, the debt ceiling, and marijuana reform.NEWS11: BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines.NEWS12: Another COVID wave could depress consumer spending, labor force participation: Economist.NEWS13: Omicron variant: The U.S. travel ban ‘makes no sense at all,’ doctor says.NEWS14: UPDATE 1-South Africa's Aspen in advanced talks over COVID-19 vaccine deal.NEWS15: COVID: 'The big concern is Delta — Omicron is not even here yet,' epidemiologist says.NEWS16: South Africa's Aspen in advanced talks over COVID-19 vaccine deal.NEWS17: UPDATE 1-COVID-19 vaccine makers start work on Omicron-tailored shots.NEWS18: COVID: Breaking down early data on Omicron variant.NEWS19: Confused about whether to get a COVID booster? Here’s what to know.

Answer: Decrease